ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 105 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 1.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $294 | -63.9% | 26,329 | +30.7% | 0.00% | -57.1% |
Q1 2023 | $815 | -99.9% | 20,147 | +57.3% | 0.01% | -22.2% |
Q3 2022 | $664,000 | +59.6% | 12,804 | +130.0% | 0.01% | +125.0% |
Q4 2021 | $416,000 | +44.4% | 5,568 | -11.5% | 0.00% | -33.3% |
Q3 2020 | $288,000 | – | 6,292 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 519,035 | $60,156,000 | 15.36% |
Matarin Capital Management, LLC | 201,703 | $23,377,378,000 | 1.69% |
ARMISTICE CAPITAL, LLC | 124,000 | $14,372,000 | 0.94% |
Sapphire Star Partners LP | 7,803 | $904,000 | 0.93% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 98,631 | $11,431,000 | 0.83% |
FARALLON CAPITAL MANAGEMENT LLC | 1,075,000 | $124,593,000 | 0.77% |
Granahan Investment Management | 100,670 | $11,668,000 | 0.70% |
Virtus ETF Advisers LLC | 6,577 | $762,000 | 0.67% |
AlphaMark Advisors, LLC | 11,115 | $1,288,000 | 0.52% |
Ativo Capital Management LLC | 15,029 | $1,742,000 | 0.48% |